

Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that is mainly employed to treat mild-to-moderate pain & reduces pain, inflammation, swelling, and stiffness. It is supplied as or contained in medications under a variety of trade names.
The global Diclofenac market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
This drug is applicable for inflammatory disorders such as arthritis, rheumatoid arthritis, dermatomyositis, osteoarthritis, dental pain, spondylarthritis, and gout attacks.
Report Includes:
This report presents an overview of global market for Diclofenac, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Diclofenac, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Diclofenac, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Diclofenac sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Diclofenac market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Diclofenac sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Auro Laboratories, Henan Dongtai, Bayer, Hunan Warrant, Istituto Biochimico, Metrix Healthcare, Simagchem Corp, Kairav Chemicals and Nipa Pharmaceuticals, etc.
By Company
Auro Laboratories
Henan Dongtai
Bayer
Hunan Warrant
Istituto Biochimico
Metrix Healthcare
Simagchem Corp
Kairav Chemicals
Nipa Pharmaceuticals
Henan PANPAN
ORIHERB
Guangdong LongFine
Xi'an Henrikang Biotech Co., Ltd.
Segment by Type
Oral
Parenteral
Segment by Application
Osteoarthritis
Ankylosing Spondylitis
Dysmenorrhea
Rheumatoid Arthritis
Migraine
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Diclofenac in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Diclofenac manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diclofenac sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Diclofenac Product Introduction
1.2 Market by Type
1.2.1 Global Diclofenac Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Diclofenac Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Osteoarthritis
1.3.3 Ankylosing Spondylitis
1.3.4 Dysmenorrhea
1.3.5 Rheumatoid Arthritis
1.3.6 Migraine
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Diclofenac Sales Estimates and Forecasts 2018-2029
2.2 Global Diclofenac Revenue by Region
2.2.1 Global Diclofenac Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Diclofenac Revenue by Region (2018-2023)
2.2.3 Global Diclofenac Revenue by Region (2024-2029)
2.2.4 Global Diclofenac Revenue Market Share by Region (2018-2029)
2.3 Global Diclofenac Sales Estimates and Forecasts 2018-2029
2.4 Global Diclofenac Sales by Region
2.4.1 Global Diclofenac Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Diclofenac Sales by Region (2018-2023)
2.4.3 Global Diclofenac Sales by Region (2024-2029)
2.4.4 Global Diclofenac Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Diclofenac Sales by Manufacturers
3.1.1 Global Diclofenac Sales by Manufacturers (2018-2023)
3.1.2 Global Diclofenac Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diclofenac in 2022
3.2 Global Diclofenac Revenue by Manufacturers
3.2.1 Global Diclofenac Revenue by Manufacturers (2018-2023)
3.2.2 Global Diclofenac Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Diclofenac Revenue in 2022
3.3 Global Key Players of Diclofenac, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Diclofenac Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Diclofenac Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Diclofenac, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Diclofenac, Product Offered and Application
3.8 Global Key Manufacturers of Diclofenac, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Diclofenac Sales by Type
4.1.1 Global Diclofenac Historical Sales by Type (2018-2023)
4.1.2 Global Diclofenac Forecasted Sales by Type (2024-2029)
4.1.3 Global Diclofenac Sales Market Share by Type (2018-2029)
4.2 Global Diclofenac Revenue by Type
4.2.1 Global Diclofenac Historical Revenue by Type (2018-2023)
4.2.2 Global Diclofenac Forecasted Revenue by Type (2024-2029)
4.2.3 Global Diclofenac Revenue Market Share by Type (2018-2029)
4.3 Global Diclofenac Price by Type
4.3.1 Global Diclofenac Price by Type (2018-2023)
4.3.2 Global Diclofenac Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Diclofenac Sales by Application
5.1.1 Global Diclofenac Historical Sales by Application (2018-2023)
5.1.2 Global Diclofenac Forecasted Sales by Application (2024-2029)
5.1.3 Global Diclofenac Sales Market Share by Application (2018-2029)
5.2 Global Diclofenac Revenue by Application
5.2.1 Global Diclofenac Historical Revenue by Application (2018-2023)
5.2.2 Global Diclofenac Forecasted Revenue by Application (2024-2029)
5.2.3 Global Diclofenac Revenue Market Share by Application (2018-2029)
5.3 Global Diclofenac Price by Application
5.3.1 Global Diclofenac Price by Application (2018-2023)
5.3.2 Global Diclofenac Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Diclofenac Market Size by Type
6.1.1 US & Canada Diclofenac Sales by Type (2018-2029)
6.1.2 US & Canada Diclofenac Revenue by Type (2018-2029)
6.2 US & Canada Diclofenac Market Size by Application
6.2.1 US & Canada Diclofenac Sales by Application (2018-2029)
6.2.2 US & Canada Diclofenac Revenue by Application (2018-2029)
6.3 US & Canada Diclofenac Market Size by Country
6.3.1 US & Canada Diclofenac Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Diclofenac Sales by Country (2018-2029)
6.3.3 US & Canada Diclofenac Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Diclofenac Market Size by Type
7.1.1 Europe Diclofenac Sales by Type (2018-2029)
7.1.2 Europe Diclofenac Revenue by Type (2018-2029)
7.2 Europe Diclofenac Market Size by Application
7.2.1 Europe Diclofenac Sales by Application (2018-2029)
7.2.2 Europe Diclofenac Revenue by Application (2018-2029)
7.3 Europe Diclofenac Market Size by Country
7.3.1 Europe Diclofenac Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Diclofenac Sales by Country (2018-2029)
7.3.3 Europe Diclofenac Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Diclofenac Market Size
8.1.1 China Diclofenac Sales (2018-2029)
8.1.2 China Diclofenac Revenue (2018-2029)
8.2 China Diclofenac Market Size by Application
8.2.1 China Diclofenac Sales by Application (2018-2029)
8.2.2 China Diclofenac Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Diclofenac Market Size by Type
9.1.1 Asia Diclofenac Sales by Type (2018-2029)
9.1.2 Asia Diclofenac Revenue by Type (2018-2029)
9.2 Asia Diclofenac Market Size by Application
9.2.1 Asia Diclofenac Sales by Application (2018-2029)
9.2.2 Asia Diclofenac Revenue by Application (2018-2029)
9.3 Asia Diclofenac Sales by Region
9.3.1 Asia Diclofenac Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Diclofenac Revenue by Region (2018-2029)
9.3.3 Asia Diclofenac Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Diclofenac Market Size by Type
10.1.1 Middle East, Africa and Latin America Diclofenac Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Diclofenac Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Diclofenac Market Size by Application
10.2.1 Middle East, Africa and Latin America Diclofenac Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Diclofenac Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Diclofenac Sales by Country
10.3.1 Middle East, Africa and Latin America Diclofenac Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Diclofenac Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Diclofenac Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Auro Laboratories
11.1.1 Auro Laboratories Company Information
11.1.2 Auro Laboratories Overview
11.1.3 Auro Laboratories Diclofenac Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Auro Laboratories Diclofenac Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Auro Laboratories Recent Developments
11.2 Henan Dongtai
11.2.1 Henan Dongtai Company Information
11.2.2 Henan Dongtai Overview
11.2.3 Henan Dongtai Diclofenac Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Henan Dongtai Diclofenac Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Henan Dongtai Recent Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Overview
11.3.3 Bayer Diclofenac Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Bayer Diclofenac Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 Hunan Warrant
11.4.1 Hunan Warrant Company Information
11.4.2 Hunan Warrant Overview
11.4.3 Hunan Warrant Diclofenac Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Hunan Warrant Diclofenac Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hunan Warrant Recent Developments
11.5 Istituto Biochimico
11.5.1 Istituto Biochimico Company Information
11.5.2 Istituto Biochimico Overview
11.5.3 Istituto Biochimico Diclofenac Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Istituto Biochimico Diclofenac Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Istituto Biochimico Recent Developments
11.6 Metrix Healthcare
11.6.1 Metrix Healthcare Company Information
11.6.2 Metrix Healthcare Overview
11.6.3 Metrix Healthcare Diclofenac Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Metrix Healthcare Diclofenac Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Metrix Healthcare Recent Developments
11.7 Simagchem Corp
11.7.1 Simagchem Corp Company Information
11.7.2 Simagchem Corp Overview
11.7.3 Simagchem Corp Diclofenac Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Simagchem Corp Diclofenac Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Simagchem Corp Recent Developments
11.8 Kairav Chemicals
11.8.1 Kairav Chemicals Company Information
11.8.2 Kairav Chemicals Overview
11.8.3 Kairav Chemicals Diclofenac Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Kairav Chemicals Diclofenac Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Kairav Chemicals Recent Developments
11.9 Nipa Pharmaceuticals
11.9.1 Nipa Pharmaceuticals Company Information
11.9.2 Nipa Pharmaceuticals Overview
11.9.3 Nipa Pharmaceuticals Diclofenac Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Nipa Pharmaceuticals Diclofenac Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Nipa Pharmaceuticals Recent Developments
11.10 Henan PANPAN
11.10.1 Henan PANPAN Company Information
11.10.2 Henan PANPAN Overview
11.10.3 Henan PANPAN Diclofenac Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Henan PANPAN Diclofenac Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Henan PANPAN Recent Developments
11.11 ORIHERB
11.11.1 ORIHERB Company Information
11.11.2 ORIHERB Overview
11.11.3 ORIHERB Diclofenac Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 ORIHERB Diclofenac Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 ORIHERB Recent Developments
11.12 Guangdong LongFine
11.12.1 Guangdong LongFine Company Information
11.12.2 Guangdong LongFine Overview
11.12.3 Guangdong LongFine Diclofenac Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Guangdong LongFine Diclofenac Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Guangdong LongFine Recent Developments
11.13 Xi'an Henrikang Biotech Co., Ltd.
11.13.1 Xi'an Henrikang Biotech Co., Ltd. Company Information
11.13.2 Xi'an Henrikang Biotech Co., Ltd. Overview
11.13.3 Xi'an Henrikang Biotech Co., Ltd. Diclofenac Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Xi'an Henrikang Biotech Co., Ltd. Diclofenac Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Xi'an Henrikang Biotech Co., Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Diclofenac Industry Chain Analysis
12.2 Diclofenac Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Diclofenac Production Mode & Process
12.4 Diclofenac Sales and Marketing
12.4.1 Diclofenac Sales Channels
12.4.2 Diclofenac Distributors
12.5 Diclofenac Customers
13 Market Dynamics
13.1 Diclofenac Industry Trends
13.2 Diclofenac Market Drivers
13.3 Diclofenac Market Challenges
13.4 Diclofenac Market Restraints
14 Key Findings in The Global Diclofenac Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Auro Laboratories
Henan Dongtai
Bayer
Hunan Warrant
Istituto Biochimico
Metrix Healthcare
Simagchem Corp
Kairav Chemicals
Nipa Pharmaceuticals
Henan PANPAN
ORIHERB
Guangdong LongFine
Xi'an Henrikang Biotech Co., Ltd.
Ìý
Ìý
*If Applicable.